Targeted Treatments for Ultra-Rare Sarcomas
Login to Watch this Webinar
To watch the live webinar, login to your account or register to gain access to our exclusive content.
Sarcomas are rare – but ultra-rare subtypes like malignant PEComa, tenosynovial giant cell tumor (TGCT), and epithelioid sarcoma present unique challenges in diagnosis, treatment planning, and toxicity management. When trial data is limited, real-world clinical strategies become essential.
In this focused session, Sasha Watson, PharmD, BCOP, will share targeted approaches to treating these uncommon malignancies—covering therapeutic options, adverse event (AE) management, and individualized care strategies when evidence is scarce and the stakes are high.
What You’ll Learn
-
Understand the incidence and clinical complexity of sarcomas, including ultra-rare subtypes.
-
Identify targeted treatment options for malignant PEComa, TGCT, and epithelioid sarcoma.
-
Manage adverse effects associated with these therapies in real-world practice.
-
Apply case-based strategies for navigating clinical uncertainty in rare cancer care.
For additional information or login assistance, reach out to NCODA’s Jonathan Rivera.
Additional Upcoming Webinars
June 25, 2026 | 2:00 PM
Upcoming Webinar
Techs Talk The Importance of Oral Health for Oncology Patients
July 8, 2026 | 3:00 PM